News

Hub provider and software company will partner for advancing cellular and genetic therapies (CGTs)

The Pharmaceutical Distribution Security Alliance proposes an industry governance process

While operating under an FAA pilot program, UPS will gear up for commercial deliveries

Model N positions itself for coming revisions in pharma trade practices

Acquires Astero Bio Corp., developer of thawing devices

The longstanding adherence problem is yielding to new technology

A changing role for hubs in collecting critical data, raising adherence

Winners were announced at HDA 2019 Distribution Management Conference

Trace Histories employs blockchain technology

Combination of a pioneering traceability provider and a leading consulting firm

Multiple locations in Mexico and Brazil can now be served more quickly

Three more locations join continents

Acquisition of daVIZta brings more analytics expertise

Company touts 12 months of rapid growth

The advantages of aligning patient recruitment and supply data

Rupture happens at a crucial time in Washington for the pharma industry

Presidential campaigns only magnify an already intense debate

$21.4-billion acquisition realigns research and manufacturing sourcing

Walgreens is one of the retailers joining in the testing program

Regulation enables better coordination of where opioids are going

The goal of producing meaningful data is driving industry progress

Agency tries to get a handle on cross-border trade

Ex-AmerisourceBergen, -Cardinal and -inVentiv Health execs join team

By working with the sales force, incentive plan design can boost a product launch

Issues include apparently diverted opioids and mislabeled medications

As the definition of ‘targeted’ therapies—especially in oncology—and as a component of companion diagnostics, biomarkers are creating opportunities in drug research and commercialization